Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Form SC 13D/A BGC Partners, Inc. Filed by: CANTOR FITZGERALD, L. P.
-
Pre-Open Movers 12/12: (FOMX) (BTAI) (CORT) Higher; (SGYP) (NBIX) (PLAY) Lower (more...)
-
UPDATE: Cantor Fitzgerald Upgrades Corcept Therapeutics (CORT) to Overweight
-
Esquire Financial (ESQ) Promotes Eric S. Bader to COO; Hires Michael Lacapria as CFO
-
Esquire Financial Holdings, Inc. Promotes Eric S. Bader To Chief Operating Officer; Hires Michael Lacapria As Chief Financial Officer
-
Makor Group Announces the Expansion of Its Foreign Exchange Division
-
Tivity Health, Inc. (TVTY) Defended at Cantor, Says 'Sell-off Overdone in Our View'
-
Orchid Island Capital Announces December 2018 Monthly Dividend and November 30, 2018 RMBS Portfolio Characteristics
-
Marinus Pharmaceuticals (MRNS) PT Raised to $25 at Cantor Fitzgerald
-
Mereo BioPharma to Present at The BMO Prescriptions for Success Healthcare Conference on 12 December 2018
-
Mereo BioPharma to Present at The BMO Prescriptions for Success Healthcare Conference on 12 December 2018
-
Global Blood Therapeutics (GBT) Says it Priced $150 Million Common Stock Public Offering
-
Global Blood Therapeutics Prices a $150.0 Million Common Stock Public Offering
-
Rambler Metals & Mining PLC Announces Convertible Loan Note Financing Close
-
Omnicell (OMCL) PT Raised to $80 at Cantor Fitzgerald
-
Global Blood Therapeutics (GBT) Announces $150M Offering of Common Stock
-
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald Downgrades Tesaro (TSRO) to Neutral Following Acquisition Offer
-
McEwen Mining Announces 2019 Timmins Exploration Strategy and Funding
-
McEwen Mining Announces 2019 Timmins Exploration Strategy and Funding
-
Proposed Combination of Mereo BioPharma and OncoMed Pharmaceuticals
-
Proposed Combination of Mereo BioPharma and OncoMed Pharmaceuticals
-
Mohr Capital Sells Industrial Building In DFW
-
Cantor Fitzgerald Upgrades Vanda Pharmaceuticals (VNDA) to Overweight
-
Anthem (ANTM) PT Raised to $330 at Cantor Fitzgerald
-
Ocular Therapeutix (OCUL) PT Raised to $24 at Cantor Fitzgerald on DEXTENZA Approval
-
GW Pharma (GWPH) PT Lowered to $193 at Cantor Fitzgerald
-
Cantor Fitzgerald Assumes Aimmune Therapeutics (AIMT) at Overweight
-
Cantor Fitzgerald Reiterates Bullish View on Global Blood Therapeutics (GBT) on Accelerated Path for Voxelotor
-
ACADIA Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Buy Amarin (AMRN) Ahead of Positive Catalysts - Cantor Fitzgerald
-
Newmark Announces Completion of Spin-Off from BGC Partners
-
BGC Partners Announces Completion of Spin-Off of Newmark
-
280 CapMarkets Launches Corporate Bonds on BondNav®
-
Freddie Mac Prices $675 Million Multifamily K-Deal, K-BF2
-
Acadia Pharma (ACAD) Prices 16.176M Share Common Offering at $17/Sh
-
Form 4 NEWMARK GROUP, INC. For: Nov 23 Filed by: CANTOR FITZGERALD, L. P.
-
ACADIA Pharmaceuticals Prices Public Offering of Common Stock
-
Form 4 BGC Partners, Inc. For: Nov 23 Filed by: CANTOR FITZGERALD, L. P.
-
AGM Report of Voting and Management Streamlining
-
Don't Count Out Proteostasis Therapeutics (PTI) Yet Despite Strong Vertex Triple Data - Cantor Fitzgerald
-
Amarin Corp. (AMRN) Prices $200M ADS Offering
-
Amarin Prices Public Offering of American Depositary Shares
-
Amarin Prices Public Offering of American Depositary Shares
-
BGC Partners Announces Distribution Ratio for Spin-Off of Newmark
-
Amarin Corp. (AMRN) to Offer ADSs
-
Amarin Announces Proposed Public Offering of American Depositary Shares
-
Amarin Announces Proposed Public Offering of American Depositary Shares
-
Cantor Fitzgerald Starts CVS Health (CVS) at Overweight
-
Mizuho Expands its Healthcare Team with the Hiring of Senior Biotechnology Research Analyst Mara Goldstein

